| 1 |
32049016 | Discovery of O-Linked Carbohydrate on HIV-1 Envelope and Its Role in Shielding against One Category of Broadly Neutralizing Antibodies. | 2020 Feb 11 |
1 |
| 2 |
32523897 | A Trispecific Anti-HIV Chimeric Antigen Receptor Containing the CCR5 N-Terminal Region. | 2020 |
1 |
| 3 |
32729597 | Influence of the reducing-end anomeric configuration of the Man9 epitope on DC-SIGN recognition. | 2020 Aug 21 |
1 |
| 4 |
33388127 | Synthetic carbohydrate-based HIV-1 vaccines. | 2020 Dec |
1 |
| 5 |
28666874 | Anti-dengue virus activity of scytovirin and evaluation of point mutation effects by molecular dynamics and binding free energy calculations. | 2017 Aug 26 |
1 |
| 6 |
26611567 | Detection and quantitative analysis of two independent binding modes of a small ligand responsible for DC-SIGN clustering. | 2016 Jan 7 |
1 |
| 7 |
27001729 | Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies. | 2016 Apr |
1 |
| 8 |
24825317 | Intracellular mannose binding lectin mediates subcellular trafficking of HIV-1 gp120 in neurons. | 2014 Sep |
1 |
| 9 |
25393493 | Recent strategies targeting HIV glycans in vaccine design. | 2014 Dec |
3 |
| 10 |
22230366 | Thioredoxin-1 and protein disulfide isomerase catalyze the reduction of similar disulfides in HIV gp120. | 2012 Mar |
2 |
| 11 |
22264046 | Combination of antiretroviral drugs as microbicides. | 2012 Jan 1 |
1 |
| 12 |
22410170 | Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN. | 2012 Jun |
1 |
| 13 |
22433013 | Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides. | 2012 Apr 18 |
1 |
| 14 |
22928048 | Glycoform and net charge heterogeneity in gp120 immunogens used in HIV vaccine trials. | 2012 |
1 |
| 15 |
23115339 | Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. | 2012 Nov 20 |
1 |
| 16 |
23198686 | Dissecting the carbohydrate specificity of the anti-HIV-1 2G12 antibody by single-molecule force spectroscopy. | 2012 Dec 21 |
1 |
| 17 |
21248038 | The V1V2 domain and an N-linked glycosylation site in the V3 loop of the HIV-1 envelope glycoprotein modulate neutralization sensitivity to the human broadly neutralizing antibody 2G12. | 2011 Apr |
1 |
| 18 |
21501631 | Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs). | 2011 Jun |
1 |
| 19 |
21972555 | [Structural mechanism of immune evasion of HIV-1 gp120 by genomic, computational, and experimental science]. | 2011 Jun |
1 |
| 20 |
20852065 | A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity. | 2010 Oct 5 |
1 |
| 21 |
19883596 | Solution and crystal molecular dynamics simulation study of m4-cyanovirin-N mutants complexed with di-mannose. | 2009 Nov 4 |
1 |
| 22 |
18434410 | An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies. | 2008 Jul |
1 |
| 23 |
18220757 | Glycosylation of HIV-1 gp120 V3 loop: towards the rational design of a synthetic carbohydrate vaccine. | 2007 |
1 |
| 24 |
16817962 | Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120. | 2006 Jul 3 |
1 |
| 25 |
19372833 | Large-molecular-weight carbohydrate-binding agents as HIV entry inhibitors targeting glycoprotein gp120. | 2006 Sep |
2 |
| 26 |
15613479 | Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. | 2005 Mar 11 |
1 |
| 27 |
15616125 | Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities. | 2005 May |
1 |
| 28 |
16253890 | Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV. | 2005 Nov |
3 |
| 29 |
15127452 | In pursuit of carbohydrate-based HIV vaccines, part 1: The total synthesis of hybrid-type gp120 fragments. | 2004 May 3 |
1 |
| 30 |
15217620 | Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology; glycan-dependent gp120/protein interactions. | 2004 Jun |
1 |
| 31 |
12626400 | The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. | 2003 Jun |
2 |
| 32 |
12689412 | Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120. | 2003 Mar |
3 |
| 33 |
12797442 | DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission. | 2003 |
1 |
| 34 |
12829775 | Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. | 2003 Jun 27 |
1 |
| 35 |
11827520 | Characterization of the tertiary structure of soluble CD4 bound to glycosylated full-length HIVgp120 by chemical modification of arginine residues and mass spectrometric analysis. | 2002 Feb 12 |
1 |
| 36 |
12054763 | Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants. | 2002 Apr 19 |
2 |
| 37 |
12110688 | Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides. | 2002 Sep 13 |
1 |
| 38 |
12270721 | Site-specific discrimination by cyanovirin-N for alpha-linked trisaccharides comprising the three arms of Man(8) and Man(9). | 2002 Sep 27 |
1 |
| 39 |
11457139 | The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120. | 2001 May 2 |
2 |
| 40 |
11591348 | Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120. | 2001 Oct |
3 |
| 41 |
10725420 | Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. | 2000 Apr |
1 |
| 42 |
11069996 | The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors. | 2000 Dec |
1 |
| 43 |
11070015 | Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases. | 2000 Dec |
1 |
| 44 |
11201791 | Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion. | 2000 Mar-Apr |
1 |
| 45 |
10364275 | Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. | 1999 Jul |
1 |
| 46 |
9591714 | Natural IgM antibodies in baby rabbit serum bind high-mannose glycans on HIV type 1 glycoprotein 120/160 and activate classic complement pathway. | 1998 May 1 |
1 |
| 47 |
9252114 | Involvement of the HIV-1 external envelope glycoprotein 120 (gp120) C2 region in gp120 oligomerization. | 1997 Jul 18 |
1 |
| 48 |
9672607 | Demonstration of peripheral fucose units in N-linked glycans of human immunodeficiency virus type 1 gp 120: effects on glycoprotein conformation. | 1997 |
2 |
| 49 |
7525987 | Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1. | 1994 Dec |
2 |
| 50 |
8457384 | The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. | 1993 Feb |
1 |